Iman Akbarzadeh

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Klebsiella Pneumoniae

Magnetic Nanoparticles

Top Venues

Journal of drug targeting

ACS applied bio materials

Nanomaterials (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mehrnoush Mehrarya, Behnaz Gharehchelou, Samin Haghighi Poodeh, Elham Jamshidifar, Sara Karimifard, Bahareh Farasati Far, Iman Akbarzadeh, Alexander Seifalian
Niosomal formulation for antibacterial applications. Journal of drug targeting 30 (5) (2022)
Maryam Mazraeh, Faten Eshrati Yeganeh, Mohammad Yousefi, Sahar Baniyaghoob, Bahareh Farasati Far, Iman Akbarzadeh, Ashkan Bigham, Milad Ashrafizadeh, Navid Rabiee, Giuseppe Perale, Mohammad Reza Saeb
Multifunctional Tetracycline-Loaded Silica-Coated Core-Shell Magnetic Nanoparticles: Antibacterial, Antibiofilm, and Cytotoxic Activities. ACS applied bio materials 5 (4) (2022)
Maryam Moghtaderi, Amir Mirzaie, Negar Zabet, Ali Moammeri, Amirreza Mansoori-Kermani, Iman Akbarzadeh, Faten Eshrati Yeganeh, Arman Chitgarzadeh, Aliasghar Bagheri Kashtali, Qun Ren
Enhanced Antibacterial Activity of Echinacea angustifolia Extract against Multidrug-Resistant Klebsiella pneumoniae through Niosome Encapsulation. Nanomaterials (Basel, Switzerland) 11 (6) (2021)
Hamidreza Sahrayi, Elham Hosseini, Sara Karimifard, Nazanin Khayam, Seyed Mohammadmahdi Meybodi, Sahar Amiri, Mahsa Bourbour, Bahareh Farasati Far, Iman Akbarzadeh, Mohammed Bhia, Clare Hoskins, Chaiyavat Chaiyasut
Co-Delivery of Letrozole and Cyclophosphamide via Folic Acid-Decorated Nanoniosomes for Breast Cancer Therapy: Synergic Effect, Augmentation of Cytotoxicity, and Apoptosis Gene Expression. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Mahsa Ghasemzad, Seyed Mohammad Reza Hashemian, Arash Memarnejadian, Iman Akbarzadeh, Nikoo Hossein-Khannazer, Massoud Vosough
The nano-based theranostics for respiratory complications of COVID-19. Drug development and industrial pharmacy (2021)